Chappelet MA, et al. – The goal of this study is to assess the impact of the topical application of a matrix regenerating agent (RGTA) in subjects with a persistent epithelial defect after bacterial keratitis treated with topical fortified antibiotics. The RGTA appears to be efficient for the treatment of a persistent epithelial defect after bacterial keratitis treated with topical fortified antibiotics.